Characterizing Kaiser Permanente Southern California’s Experience With the California End of Life Option Act in the First Year of Implementation The California End of Life Option Act (EOLOA),1 which took effect on June 9, 2016, allows qualified adults diagnosed with a terminal disease to request aid-in-dying drugs from their physician. The California Department of Public Health recently published data on 191 individuals who received aid-in-dying prescriptions during the act’s first 6 months.2 In response to recommendations for more comprehensive documentation of EOLOA implementation to improve end-of-life care,3 this study describes the experience of a large integrated health system and provides in-depth descriptions of individuals who initiated the EOLOA process.

中文翻译：

---

描述 Kaiser Permanente Southern California 在《加州生命终结选择权法案》实施第一年的经验

描述 Kaiser Permanente Southern California 在加州生命终结选择法案实施第一年的经验 加州生命终结选择法案 (EOLOA)1 于 2016 年 6 月 9 日生效，允许被诊断患有绝症的合格成年人向他们的医生请求急救药物。加州公共卫生部最近公布了 191 人在该法案的前 6 个月内接受了临终救助处方的数据。 2 为了回应关于更全面地记录 EOLOA 实施以改善临终关怀的建议，3研究描述了大型综合卫生系统的经验，并对发起 EOLOA 流程的个人进行了深入描述。